Profile data is unavailable for this security.
About the company
InventisBio Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main product is still in clinical development. The Company's core products mainly focus on major disease areas such as oncology and metabolic diseases. The Company's products include D-0120, D-0502, D-1553, BPI-D0316 and others.
- Revenue in CNY (TTM)77.51m
- Net income in CNY-348.02m
- Incorporated2013
- Employees221.00
- LocationInventisBio Co LtdNo.4 Building, Lane 67, Libing RoadSHANGHAI 201203ChinaCHN
- Phone+86 2 150778527
- Fax+86 2 150778527
- Websitehttp://www.inventisbio.com/
More ▼
Mergers & acquisitions
| Acquired company | 688382:SHH since announced | Transaction value |
|---|---|---|
| Lyvgen Biopharma Holdings Ltd-Assets | -4.33% | 211.00k |
Data delayed at least 15 minutes, as of Nov 22 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Vland Biotech INC | 1.26bn | 66.23m | 3.52bn | 1.57k | 52.84 | 2.04 | -- | 2.78 | 0.2631 | 0.2631 | 5.02 | 6.83 | 0.425 | 3.78 | 3.76 | 805,143.80 | 3.25 | 5.78 | 5.09 | 7.89 | 44.98 | 46.13 | 7.65 | 10.34 | 0.9248 | 11.63 | 0.2904 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Hinova Pharmaceuticals Inc | 109.74k | -210.18m | 3.59bn | 179.00 | -- | 2.92 | -- | 32,725.49 | -2.12 | -2.12 | 0.0011 | 12.44 | 0.00007 | 7.12 | 0.0805 | 613.07 | -14.10 | -31.86 | -15.71 | -37.18 | -450.31 | -- | -191,529.30 | -25,578.24 | 6.38 | -- | 0.0457 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Bide Pharmatech Co Ltd | 1.10bn | 80.03m | 4.20bn | 846.00 | 51.49 | 2.10 | -- | 3.83 | 0.8983 | 0.8983 | 12.25 | 21.98 | 0.4608 | 0.9359 | 4.51 | 1,298,144.00 | 3.34 | -- | 3.82 | -- | 40.11 | -- | 7.25 | -- | 4.59 | -- | 0.0492 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 497.71m | 103.71m | 4.36bn | 566.00 | 35.39 | 4.19 | -- | 8.76 | 0.4439 | 0.4439 | 1.98 | 3.75 | 0.3103 | 0.3818 | 9.08 | 879,345.60 | 7.20 | 8.83 | 8.22 | 9.61 | 61.57 | 61.49 | 23.21 | 26.85 | 3.10 | 113.47 | 0.2781 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Jiangsu Yahong Meditech Co Ltd | 149.71m | -403.23m | 4.41bn | 394.00 | -- | 2.12 | -- | 29.47 | -0.7074 | -0.7074 | 0.2627 | 3.65 | 0.0598 | 16.64 | 6.92 | 379,971.80 | -16.14 | -15.80 | -17.15 | -16.48 | 78.63 | 55.32 | -269.87 | -9,445.91 | 8.97 | -- | 0.0599 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.42bn | 134.34m | 4.61bn | 584.00 | 33.01 | 2.48 | -- | 3.25 | 0.8175 | 0.8175 | 8.53 | 10.87 | 0.5736 | 1.80 | 3.27 | 2,431,971.00 | 6.49 | 5.31 | 8.52 | 6.76 | 81.80 | 86.02 | 11.31 | 8.10 | 2.91 | -- | 0.141 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.16bn | 221.37m | 4.79bn | 1.39k | 21.62 | 4.23 | -- | 4.14 | 1.98 | 1.98 | 10.33 | 10.10 | 0.6079 | 35.95 | 1.77 | 844,377.10 | 11.25 | 12.99 | 18.76 | 21.70 | 53.30 | 53.93 | 18.50 | 21.34 | 1.86 | 29.92 | 0.3068 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| HitGen Inc | 423.87m | 52.55m | 5.08bn | 452.00 | 96.47 | 3.69 | -- | 11.99 | 0.1314 | 0.1314 | 1.06 | 3.44 | 0.248 | 7.10 | 4.55 | 937,755.30 | 2.99 | 4.63 | 3.16 | 5.10 | 51.23 | 58.89 | 12.05 | 20.66 | 16.15 | 38.23 | 0.1391 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
| Shanghai Medicilon Inc | 984.17m | -276.79m | 5.11bn | 2.42k | -- | 2.17 | -- | 5.19 | -2.01 | -2.01 | 7.23 | 17.46 | 0.3029 | 6.90 | 1.27 | 378,525.60 | -8.52 | 9.34 | -10.66 | 11.73 | 0.6443 | 36.71 | -28.12 | 14.93 | 2.64 | -- | 0.1147 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| GemPharmatech Co Ltd | 677.34m | 139.41m | 5.63bn | 1.51k | 40.00 | 2.64 | -- | 8.30 | 0.343 | 0.343 | 1.65 | 5.20 | 0.2703 | 4.54 | 2.06 | 449,761.40 | 5.56 | 9.45 | 6.39 | 11.13 | 63.04 | 70.21 | 20.58 | 28.16 | 4.74 | -- | 0.0509 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
| InventisBio Co Ltd | 77.51m | -348.02m | 6.17bn | 221.00 | -- | 3.56 | -- | 79.61 | -0.6064 | -0.6064 | 0.1346 | 3.01 | 0.0383 | -- | 0.5855 | 350,739.20 | -17.19 | -- | -18.36 | -- | 90.80 | -- | -448.98 | -- | -- | -- | 0.0138 | -- | -- | -- | 41.26 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to InventisBio Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
18.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2024 | 18.59m | 4.65% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 18.18m | 4.55% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 7.23m | 1.81% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 7.21m | 1.80% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 6.18m | 1.55% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2024 | 5.34m | 1.34% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 4.33m | 1.08% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 3.74m | 0.94% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 2.21m | 0.55% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 1.63m | 0.41% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
